Literature DB >> 28960380

Distinct role of nuclear receptor corepressor 1 regulated de novo fatty acids synthesis in liver regeneration and hepatocarcinogenesis in mice.

Qing Ou-Yang1,2,3, Xi-Meng Lin1, Yan-Jing Zhu1,4, Bo Zheng1,4, Liang Li1,4, Ying-Cheng Yang1, Guo-Jun Hou1, Xin Chen1,4, Gui-Juan Luo1,4, Feng Huo3, Qi-Bin Leng5, Frank J Gonzalez6, Xiao-Qing Jiang2, Hong-Yang Wang1,4, Lei Chen1,4,7.   

Abstract

It is urgent that the means to improve liver regeneration (LR) be found, while mitigating the concurrent risk of hepatocarcinogenesis (HCG). Nuclear receptor corepressor 1 (NCoR1) is a co-repressor of nuclear receptors, which regulates the expression level of metabolic genes; however, little is known about its potential contribution for LR and HCG. Here, we found that liver-specific NCoR1 knockout in mice (NCoR1Δhep ) dramatically enhances LR after partial hepatectomy and, surprisingly, blocks the process of diethylnitrosamine (DEN)-induced HCG. Both RNA-sequencing and metabolic assay results revealed improved expression of Fasn and Acc2 in NCoR1Δhep mice, suggesting the critical role of de novo fatty acid synthesis (FAS) in LR. Continual enhanced de novo FAS in NCoR1Δhep mice resulted in overwhelmed adenosine triphosphate ATP and nicotinamide adenine dinucleotide phosphate (NADPH) consumption and increased mitochondrial reactive oxygen species production, which subsequently attenuated HCG through inducing apoptosis of hepatocytes at an early stage after DEN administration.
CONCLUSION: NCoR1 functions as a negative modulator for hepatic de novo FAS and mitochondria energy adaptation, playing distinct roles in regeneration or carcinogenesis. (Hepatology 2018;67:1071-1087).
© 2017 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28960380      PMCID: PMC6661113          DOI: 10.1002/hep.29562

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  5 in total

1.  Hepatic NCoR1 deletion exacerbates alcohol-induced liver injury in mice by promoting CCL2-mediated monocyte-derived macrophage infiltration.

Authors:  Fan Yin; Miao-Miao Wu; Xiao-Li Wei; Rui-Xue Ren; Meng-Hua Liu; Chong-Qing Chen; Liu Yang; Rui-Qian Xie; Shan-Yue Jiang; Xue-Fu Wang; Hua Wang
Journal:  Acta Pharmacol Sin       Date:  2022-02-11       Impact factor: 7.169

2.  A novel immune signature to predict the prognosis of patients with hepatocellular carcinoma.

Authors:  Qinghe Li; Bin Fan; Jun Ding; Xiaoxi Xiang; Jian Zhang
Journal:  Medicine (Baltimore)       Date:  2021-08-20       Impact factor: 1.817

3.  Calotropis gigantea stem bark extracts inhibit liver cancer induced by diethylnitrosamine.

Authors:  Suphunwadee Sawong; Dumrongsak Pekthong; Supawadee Parhira; Piyarat Srisawang; Pennapha Suknoppakit; Thanwarat Winitchaikul; Worasak Kaewkong; Julintorn Somran; Chaidan Intapa
Journal:  Sci Rep       Date:  2022-07-15       Impact factor: 4.996

4.  SeqVItA: Sequence Variant Identification and Annotation Platform for Next Generation Sequencing Data.

Authors:  Prashanthi Dharanipragada; Sampreeth Reddy Seelam; Nita Parekh
Journal:  Front Genet       Date:  2018-11-14       Impact factor: 4.599

5.  Knowledge-based analyses reveal new candidate genes associated with risk of hepatitis B virus related hepatocellular carcinoma.

Authors:  Deke Jiang; Jiaen Deng; Changzheng Dong; Xiaopin Ma; Qianyi Xiao; Bin Zhou; Chou Yang; Lin Wei; Carly Conran; S Lilly Zheng; Irene Oi-Lin Ng; Long Yu; Jianfeng Xu; Pak C Sham; Xiaolong Qi; Jinlin Hou; Yuan Ji; Guangwen Cao; Miaoxin Li
Journal:  BMC Cancer       Date:  2020-05-11       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.